Loading...
XJPX
2053
Market cap347mUSD
Oct 09, Last price  
1,941.00JPY
1D
1.62%
1Q
1.78%
Jan 2017
91.04%
Name

Chubushiryo Co Ltd

Chart & performance

D1W1MN
XJPX:2053 chart
P/E
10.03
P/S
0.26
EPS
193.47
Div yield, %
2.98%
Shrs. gr., 5y
-0.60%
Rev. gr., 5y
3.15%
Revenues
211.81b
+0.94%
126,189,715,000149,095,651,000124,297,000,000121,804,000,000135,328,000,000136,473,000,000152,879,000,000154,984,000,000170,172,000,000171,054,000,000178,235,000,000186,982,000,000183,428,000,000181,356,000,000193,392,000,000243,476,000,000234,227,000,000209,837,000,000211,814,000,000
Net income
5.55b
+58.63%
1,488,885,0001,524,852,0002,429,000,000819,000,0001,341,000,0001,275,000,0001,945,000,0001,614,000,0002,609,000,0003,423,000,0004,252,000,0003,795,000,0004,732,000,0003,782,000,0003,211,000,000827,000,0003,327,000,0003,500,000,0005,552,000,000
CFO
7.19b
-40.02%
1,261,146,0006,171,536,0005,238,000,0002,191,000,0002,667,000,000973,000,0004,135,000,0004,085,000,0005,028,000,00010,219,000,0002,022,000,0003,461,000,00011,915,000,0005,281,000,000-2,466,000,000-6,478,000,00010,370,000,00011,992,000,0007,193,000,000
Dividend
Mar 30, 202738 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chubu Shiryo Co., Ltd., a Japanese enterprise, specializes in the development and distribution of compound animal feeds for both the agricultural and aquaculture industries. Their product line features specialized nutrition for poultry, swine, cattle, and various fish farming operations. Beyond feed, the company also markets livestock and marine products directly to retailers such as supermarkets and department stores, as well as to the hospitality sector. Chubu Shiryo further extends its activities to include the manufacturing and sale of organic composite fertilizers, the provision of sales and maintenance services for livestock equipment, and the offering of non-life insurance for livestock. Additionally, they provide essential veterinary support services, including hygiene protocols, pathological diagnostics, and expert guidance for breeding practices. Established in 1949, the company's main office is located in Nagoya, Japan.

Key people

Kyoichi Fujita
President, Representative Director · since 2025
Yutaka Ushida
Executive Officer, Director of Finance and Accounting · since 2023
Toshihiro Ito
Vice President, Chief Director of Business, Chief Director of Administration, Director · since 2025
Kazuo Zenya
Senior Managing Director, Chief Director of Feed · since 2025
Takuichi Makino
Senior Executive Officer, Director of Egg Business · since 2024
Hideki Matsukura
Senior Executive Officer, Manager of Mizushima Plant · since 2025
Takahiro Yoshida
Senior Executive Officer, Manager of Hachinohe Plant, Manager of Tohoku Answer Farm · since 2025
Nozomi Mizuha
Executive Officer, Director of General Affairs and Human Resource · since 2025
Noboru Aoki
Executive Officer, Manager of Internal Audit Office · since 2025
Tsutomu Imaeda
Executive Officer, Director of Fertilizer · since 2023
Toshiya Nonaka
Executive Officer, Manager of Chita Plant · since 2024
Keiji Wayama
Executive Officer, Manager of Hokkaido Plant · since 2024
Takashi Yamaguchi
Executive Officer, Director of Purchasing · since 2024
Harunobu Hirano
Director · since 2025
Atsushi Kamei
Independent Director · since 2022
Yuki Shibata
Independent Director · since 2022
Hiroko Tsukamura
Independent Director · since 2024
IPO date
Oct 02, 1961
Employees
509
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT